Adrenal gland
Adrenal gland is a little organ that hangs-out above the kidney. Pathologists rarely see it. It uncommonly is affected by tumours.
Anatomy & histology
Anatomy
- Cortex.
- Medulla.
Histology
It is composed of a cortex and a medulla.
Cortex
It has three layers - mnemonic: GFR (from superficial to deep):
- Zona glomerulosa - salt (e.g. aldosterone).
- Eosinophilic cytoplasm. (???)
- Layer normally discontinuous.
- Zona fasciculata - sugar (e.g. cortisol).
- Clear cytoplasm - key feature.
- Largest part of the cortex ~ 70%.
- Cells in cords/nests. (???)
- Zona reticularis - steroid (e.g. dehydroepiandrosterone).
- Marked eosinophilia of cytoplasm - key feature.
- Granular/reticular cytoplasm.
Medulla
It consists of two cell types:[1]
- Chromaffin cells.
- Arise of neural crest.
- Sustentacular cells (supporting cells).
Produce NED: norepinephrine, epinephrine, dopamine.
Clinical
Patients getting a bilateral adrenalectomy get pre-treatment with steroids.[2]
Adrenal insufficiency is an immediate danger post-op.[3]
Benign
The section covers non-neoplastic pathologies of the adrenal gland. These uncommonly come to the pathologist.
Stress response
- In fetuses - fat content increases due to stress[4] -- see: Fetal_autopsy#Adrenal_fetal_fat_pattern.
- In newborns/children/adults - fat content decreases due to stress.
Spironolactone bodies
Features:[5]
- Location: zona glomerulosa (where aldosterone is produced).
- Appearance: eosinophilic spherical laminated whorls.
- Etiology: long-term use of spironolactone.
Images:
Hemorrhagic adrenalitis
General
- AKA Waterhouse-Friderichsen syndrome.
- Classically thought to be only due to Neisseria meningitidis; however, more recently also associated with Streptococcus aureus.[6][7]
Gross
Features:
- Massive haemorrhage within the substance of the adrenal gland.
DDx (autopsy):
- Post-mortem changes.
Microscopic
Features:
- Massive haemorrhage within the substance of the adrenal gland.
Image: Haemorrhage in adrenal (nih.gov).
Adrenal cytomegaly
General
May be associated with:[8]
- Beckwith-Wiedemann syndrome.
- Prematurity.
- Rh-incompatibility.[9]
Microscopic
Features:
- Large cells in the adrenal cortex.[9]
Addison disease
General
- Chronic adrenocortical insufficiency.
Clinical:
- Brown skin - due POMC (a precursor of ACTH and melanocyte stimulating hormone (MSH)).[10]
- POMC presence implies the pituitary gland intact.
- Hypotension.
- Nausea and vomiting.
DDx:[11]
- Autoimmune.
- Tuberculosis.
- AIDS.
- Malignancy.
Notes:
- Secondary adrenocortical insufficiency (due to pituitary pathology):[12]
- No hyperpigmentation (as no POMC).
- Aldosterone usu. normal.
Microscopic
Features:[10]
- Atrophy adrenal cortex - specifically zona fasciculata and zona reticularis.
Notes:
- There is preservation of zona glomerulosa and medulla.
Benign neoplasms
Adrenal cortical adenoma
General
Epidemiology:
- Often an incidental finding.
Pathologic/clinical:
- May be hormonally active.
- Radiologists are good at identifying adenomas, as they are usually lipid rich and have a characteristic low HU signal.[13]
Indications for excision:[14][15]
- Lesions >30 mm.
- Hormonally active.
- Non-incidental finding. (???)
Microscopic
Classic features:
- Well-defined cell borders.
- Clear cytoplasm.
- May have foci of necrosis/degeneration and nuclear atypia.
In aldosterone producing tumours:
- May extend outside of the capsule (should not be diagnosed as adrenal cortical carcinoma).
- No atrophy of non-hyperplastic cortex.
In cortisol producing tumours (Cushing syndrome):
- Atrophy of the non-hyperplastic cortex (due to feedback inhibition from the pituitary gland).
Notes:
- Cushing disease is due to the ACTH over-production by the pituitary.
- Adrenal hyperplasia vs. adrenal adenoma:
- Hyperplasia is multifocal.[16]
Pheochromocytoma
General
- Considered to be a paraganglioma.[17]
- Literally means "dusky" (pheo) "colour" (chromo) - dull appearance on gross.
- Tumour arises from adrenal medulla - chromaffin cells.[18]
Memory device - the rule of 10s:[18]
- 10% extra-adrenal (e.g. carotid body, organ of Zuckerkandl (neighourhood of aortic bifuration/IMA branch point)).
- 10% bilateral.
- 10% malignant.
- 10% no hypertension.
- 25% associated within a syndrome:
- Multiple endocrine neoplasia 2A and 2B.
- von Hippel-Lindau syndrome.
- Neurofibromatosis type 1.
- Familial paraganglioma syndromes - several.
Clinical
- Classic finding: hypertension.
- Paroxysms (i.e. episodes) of tachycardia, headache, anxiety, hypertension.
Laboratory findings (urine):
- Vanillylmandelic acid (VMA).
- Metanephrines.
Microscopic
Features:[19]
- Chief cells:
- Usu. polygonal cells, may be spindled.
- Arranged in cell nests - "Zellballen" (literally cell balls) - key feature.
- Stippled chromatin (AKA salt and pepper chromatin) - coarsely granular chromatin.
- Granular cytoplasm, often basophilic - important.
- Sustentacular cells (structural support cell).
- Often haemorrhagic - highly vascular.
- +/-Nuclear pleomorphism.
Notes:
- The nested architecture (Zellballen) is useful for differentiating from ACC.
- Metastasis sole criteria of malignancy.[18]
Images:
DDx:
Pheochromocytoma versus adrenal cortical carcinoma
- Pheochromocytoma and adrenal cortical carcinoma overlap histologically.[20]
Favour pheochromocytoma:
- Small chickenwire-pattern blood vessels, nests, salt-and-pepper chromatin, red blood cell extravasation.
Favour adrenal cortical carcinoma:
- Nucleolus, sheeting.
Malignant pheochromoctyoma
- Robbins says metastases are the sole criteria of malignancy.[18]
- Thompson suggests one can differentiate benign from malignant with the aid of the following:[21]
- Marked nuclear atypia.
- Invasion:
- Capsular.
- Vascular.
- Necrosis.
- Cellular monotony.
- Mitoses:
- Rate.
- Atypical mitosis.
IHC
- Chief cells:
- Chromogranin A +ve.
- Synaptophysin +ve.
- Sustentacular cells:
- S100 +ve.
EM
- Membrane-bound secretory granules.
Ganglioneuroma
Microscopic
Features:
- Ganglion cells - key feature.
- Large cells with large nucleus.
- Prominent nucleolus.
- Large cells with large nucleus.
- Disordered fibrinous material.
Images:
See: CNS tumours.
Adrenal myelolipoma
General
- Benign and rare.
- Typically asymptomatic and hormonally inactive.[22]
- Symptoms: back or abdominal pain.
- Diagnosis - usu. by abdominal CT.
Treatment:
- Watchful waiting if small (<=7 cm) and asymptomatic.[22]
Microscopic
Features:[23]
- Adipose tissue.
- Hematopoietic elements from all three lineages:
- Erythroid.
- Myeloid.
- Megakaryocytic.
- +/-Calcification.[22]
DDx:
- Angiomyolipoma of the kidney.
- Lipoma.
- Liposarcoma.
Images:
Adenomatoid tumour
See: Adenomatoid tumours (uterine tumours).
Malignant neoplasms
Adrenocortical carcinoma
- AKA adrenal cortical carcinoma.
- Abbreviated ACC.
General
- Prognosis sucks, esp. in adults.
Epidemiology:
- May be associated with a syndrome:[10]
Gross
- +/-Encapsulated.
- Necrotic-appearing.
Image:
Microscopic
Various criteria exist for this diagnosis. The most widely used is the Weiss criteria, which is a big long clunker.
Image:
- WC:
- www:
Notes:
- Tumour may contain fat.[24]
Adult
Weiss criteria
Three of the following:[25]
- High nuclear grade.
- High mitotic rate; >5/50 HPF (@ 40X obj.) - definition suffers from HPFitis.
- Atypical mitoses.
- Cleared cytoplasm in >= 25% of tumour cells.
- Sheeting (diffuse architecture) in >= 1/3 of tumour cells.
- Necrosis in nests.
- Venous invasion.
- Adrenal sinusoid invasion; lymphovascular space invasion within the adrenal gland.
- Capsular invasion.
Volante criteria
There is a simplified set of criteria by Volante et al. - that is not widely used:[26]
- Reticular network disruption (with reticulin staining).
- One of the three following:
- Abundant mitoses >5/50 high-power fields - definition suffers from HPFitis.
- Necrosis.
- Vascular invasion.
Pediatric
The criteria in the pediatric setting are somewhat different. This is discussed by Wieneke et al.[27] and Dehner and Hill.[28]
Dehner and Hill propose a very simple system:[28]
- "Low risk" < 200 g & confined to the adrenal.
- "Intermediate risk" 200-400 g, no mets, +/-microscopic disease outside adrenal.
- "High risk" >400 g, or mets, or gross invasion of adjacent structures.
IHC
- Vimentin +ve.
- Melan A +ve.
- Inhibin-alpha +ve.
- Cytokeratins +ve/-ve.
Others:
- Synaptophysin +ve/-ve.
- Chromogranin -ve.
- Pheochromocytoma +ve.
- EMA -ve.
- Renal cell carcinoma +ve.
- S100 -ve.
- Pheochromocytoma +ve (sustentacular cells).[29]
Neuroblastoma
- See also: olfactory neuroblastoma.
General
Laboratory:
- Increased urine homovanillic acid.
Epidemiology:
- Usually paediatric population.
Classification:
- In a grouping known as neuoblastic tumours which includes:[30]
- Ganglioneuroma (benign).
- Ganglioblastoma (intermediate).
- Neuroblastoma (aggressive).
Gross
- ~40% of in the adrenal gland.[31]
Microscopic
Features:[32]
- Small round blue cells separated by thin (pink) fibrous septa.
- Homer-Wright rosettes.
- Rosette with a small (~100 micrometers - diameter) meshwork of fibers (neuropil) at the centre.[33]
- Neuropil-like stroma = paucicellular stroma with a cotton candy-like appearance; see comparison below.
- >50% neuropil-like stroma -- otherwise it's a ganglioneurona or ganglioblastoma.
Notes:
- The fibrous septa are esp. useful for differentiation from lymphoma.
DDx:
Images:
Schwannian vs. neuropil
Feature | Schwannian | Neuropil |
Cellularity | high ~ spacing of cells < 30 µm | low ~ spacing of cells > 100 µm |
Fibrillary | yes, long fine strands | no |
Associations | ganglion cells | neuroblasts |
Cytoplasmic vacuolation | yes | ? |
Classification/grading
Commonly grouped by the Shimada classification, which depends on the presence a number of things including:
- Mitoses/karyorrhectic cells.
- Molecular abnormalities.
IHC
- PGP 9.5 +ve.[35]
- PGP = protein gene product.
See also
References
- ↑ Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson; Aster, Jon (2009). Robbins and Cotran pathologic basis of disease (8th ed.). Elsevier Saunders. pp. 1159. ISBN 978-1416031215.
- ↑ URL: http://www3.interscience.wiley.com/cgi-bin/fulltext/119909358/PDFSTART. Accessed on: 21 August 2010.
- ↑ URL: http://ats.ctsnetjournals.org/cgi/content/full/62/5/1516. Accessed on: 21 August 2010.
- ↑ Becker MJ, Becker AE (September 1976). "Fat distribution in the adrenal cortex as an indication of the mode of intrauterine death". Hum. Pathol. 7 (5): 495–504. PMID 964978.
- ↑ Kovacs K, Horvath E, Singer W (December 1973). "Fine structure and morphogenesis of spironolactone bodies in the zona glomerulosa of the human adrenal cortex". J. Clin. Pathol. 26 (12): 949-57. PMC 477936. PMID 4131694. http://jcp.bmj.com/cgi/pmidlookup?view=long&pmid=4131694.
- ↑ Adem PV, Montgomery CP, Husain AN, et al. (September 2005). "Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children". N. Engl. J. Med. 353 (12): 1245–51. doi:10.1056/NEJMoa044194. PMID 16177250.
- ↑ Hamilton D, Harris MD, Foweraker J, Gresham GA (February 2004). "Waterhouse-Friderichsen syndrome as a result of non-meningococcal infection". J. Clin. Pathol. 57 (2): 208–9. PMC 1770213. PMID 14747454. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1770213/.
- ↑ URL: http://www.humpath.com/?adrenal-cytomegaly. Accessed on: 3 January 2012.
- ↑ 9.0 9.1 Aterman, K.; Kerenyi, N.; Lee, M. (1972). "Adrenal cytomegaly.". Virchows Arch A Pathol Pathol Anat 355 (2): 105-22. PMID 4336262.
- ↑ 10.0 10.1 10.2 Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson; Aster, Jon (2009). Robbins and Cotran pathologic basis of disease (8th ed.). Elsevier Saunders. pp. 1157. ISBN 978-1416031215.
- ↑ Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson; Aster, Jon (2009). Robbins and Cotran pathologic basis of disease (8th ed.). Elsevier Saunders. pp. 1155. ISBN 978-1416031215.
- ↑ Mitchell, Richard; Kumar, Vinay; Fausto, Nelson; Abbas, Abul K.; Aster, Jon (2011). Pocket Companion to Robbins & Cotran Pathologic Basis of Disease (8th ed.). Elsevier Saunders. pp. 585. ISBN 978-1416054542.
- ↑ URL: http://emedicine.medscape.com/article/376240-overview.
- ↑ Luton, JP.; Martinez, M.; Coste, J.; Bertherat, J. (Jul 2000). "Outcome in patients with adrenal incidentaloma selected for surgery: an analysis of 88 cases investigated in a single clinical center.". Eur J Endocrinol 143 (1): 111-7. PMID 10870039.
- ↑ Liu, XK.; Liu, XJ.; Dong, X.; Kong, CZ. (Jun 2008). "[Clinical research about treatment for adrenal incidentalomas]". Zhonghua Wai Ke Za Zhi 46 (11): 832-4. PMID 19035218.
- ↑ IAV. 18 February 2009.
- ↑ Thompson, Lester D. R. (2006). Endocrine Pathology: A Volume in Foundations in Diagnostic Pathology Series (1st ed.). Churchill Livingstone. pp. 327. ISBN 978-0443066856.
- ↑ 18.0 18.1 18.2 18.3 Mitchell, Richard; Kumar, Vinay; Fausto, Nelson; Abbas, Abul K.; Aster, Jon (2011). Pocket Companion to Robbins & Cotran Pathologic Basis of Disease (8th ed.). Elsevier Saunders. pp. 586. ISBN 978-1416054542.
- ↑ Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson; Aster, Jon (2009). Robbins and Cotran pathologic basis of disease (8th ed.). Elsevier Saunders. pp. 1161. ISBN 978-1416031215.
- ↑ Sangoi, AR.; McKenney, JK. (Mar 2010). "A tissue microarray-based comparative analysis of novel and traditional immunohistochemical markers in the distinction between adrenal cortical lesions and pheochromocytoma.". Am J Surg Pathol 34 (3): 423-32. doi:10.1097/PAS.0b013e3181cfb506. PMID 20154585.
- ↑ Thompson, Lester D. R. (2006). Endocrine Pathology: A Volume in Foundations in Diagnostic Pathology Series (1st ed.). Churchill Livingstone. pp. 259. ISBN 978-0443066856.
- ↑ 22.0 22.1 22.2 Daneshmand, S.; Quek, ML. (2006). "Adrenal myelolipoma: diagnosis and management.". Urol J 3 (2): 71-4. PMID 17590837.
- ↑ 23.0 23.1 Cha, JS.; Shin, YS.; Kim, MK.; Kim, HJ. (Aug 2011). "Myelolipomas of both adrenal glands.". Korean J Urol 52 (8): 582-5. doi:10.4111/kju.2011.52.8.582. PMC 3162227. PMID 21927708. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162227/.
- ↑ Heye S, Woestenborghs H, Van Kerkhove F, Oyen R (2005). "Adrenocortical carcinoma with fat inclusion: case report". Abdom Imaging 30 (5): 641–3. doi:10.1007/s00261-004-0281-5. PMID 15688105.
- ↑ Jain M, Kapoor S, Mishra A, Gupta S, Agarwal A (2010). "Weiss criteria in large adrenocortical tumors: a validation study". Indian J Pathol Microbiol 53 (2): 222–6. doi:10.4103/0377-4929.64325. PMID 20551521.
- ↑ Volante M, Bollito E, Sperone P, et al. (November 2009). "Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification". Histopathology 55 (5): 535–43. doi:10.1111/j.1365-2559.2009.03423.x. PMID 19912359.
- ↑ Wieneke JA, Thompson LD, Heffess CS (July 2003). "Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients". Am. J. Surg. Pathol. 27 (7): 867–81. PMID 12826878.
- ↑ 28.0 28.1 Dehner LP, Hill DA (2009). "Adrenal cortical neoplasms in children: why so many carcinomas and yet so many survivors?". Pediatr. Dev. Pathol. 12 (4): 284–91. doi:10.2350/08-06-0489.1. PMID 19326954.
- ↑ Unger P, Hoffman K, Pertsemlidis D, Thung S, Wolfe D, Kaneko M (May 1991). "S100 protein-positive sustentacular cells in malignant and locally aggressive adrenal pheochromocytomas". Arch. Pathol. Lab. Med. 115 (5): 484–7. PMID 1673596.
- ↑ Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B (July 1999). "Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee". Cancer 86 (2): 349–63. PMID 10421272.
- ↑ Mitchell, Richard; Kumar, Vinay; Fausto, Nelson; Abbas, Abul K.; Aster, Jon (2011). Pocket Companion to Robbins & Cotran Pathologic Basis of Disease (8th ed.). Elsevier Saunders. pp. 253. ISBN 978-1416054542.
- ↑ Chung EM, Murphey MD, Specht CS, Cube R, Smirniotopoulos JG (2008). "From the Archives of the AFIP. Pediatric orbit tumors and tumorlike lesions: osseous lesions of the orbit". Radiographics 28 (4): 1193–214. doi:10.1148/rg.284085013. PMID 18635637.
- ↑ Wippold FJ, Perry A (March 2006). "Neuropathology for the neuroradiologist: rosettes and pseudorosettes". AJNR Am J Neuroradiol 27 (3): 488–92. PMID 16551982.
- ↑ URL: http://radiographics.rsna.org/content/28/4/1193.full. Accessed on: 12 January 2011.
- ↑ Ootsuka, S.; Asami, S.; Sasaki, T.; Yoshida, Y.; Nemoto, N.; Shichino, H.; Chin, M.; Mugishima, H. et al. (Jun 2008). "Useful markers for detecting minimal residual disease in cases of neuroblastoma.". Biol Pharm Bull 31 (6): 1071-4. PMID 18520032.